Connect your AI

Cerus CERS Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Bio-Rad LaboratoriesBIO

4.8%+0.7pp

Protagonist TherapeuticsPTGX

$7.39M-17.9%

QuidelOrtho CorporationQDEL

$158M-4.2%

ADMA BiologicsADMA

$6.4M-20.2%

PaysignPAYS

$5.52M+9,204,624,900%

Other financials

Income statement

Revenue$53.7M+24.1%

Operating income-$354.0K+94.0%

Net income-$1.6M+78.7%

EPS (diluted)-$0.01+75.0%

Balance sheet

Cash & equivalents$27.9M+43.0%

Total debt$45.0M-43.3%

Total equity$67.6M+21.7%

Total assets$222.9M+7.8%

Cash flow

Operating cash flow-$3.0M-261%

CapEx$233.0K+108%

Free cash flow-$3.3M-243%

Valuation

Market cap$573.06M+124%

Enterprise value$590.17M+86.7%

P/S2.9×-1.0×

Profitability

Gross margin64%—

Operating margin-6.2%-2.1pp

Net margin-9.8%-2.8pp

FCF margin3.5%+1.9pp

Returns & leverage

Return on equity-15.5%-5.6pp

Debt / equity0.7×-0.8×

Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Cerus's operating lease ROU assets?: Cerus (CERS) reported operating lease ROU assets of $9.45M in Q1 2026.
How has Cerus's operating lease ROU assets changed year-over-year?: Cerus's operating lease ROU assets increased by 3.8% year-over-year, from $9.1M to $9.45M.
What is the long-term trend for Cerus's operating lease ROU assets?: Over 5 years (2020 to 2025), Cerus's operating lease ROU assets has grown at a -5.1% compound annual growth rate (CAGR), from $13.12M to $10.12M.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.